J. Lieberman

发表

Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

J. Lieberman, 1975, The American journal of medicine.

Elevation of serum angiotensin-converting enzyme in Gaucher's disease.

E. Beutler, J. Lieberman, 1976, The New England journal of medicine.

Angiotensin-converting enzyme activity in postmortem human tissues.

A. Sastre, J. Lieberman, 1983, Laboratory investigation; a journal of technical methods and pathology.

Cyclic Fluctuation of Sweat Electrolytes in Women: Effect of Polythiazide Upon Sweat Electrolytes

J. Lieberman, 1966 .

Glutamic oxalacetic transaminase in serum and cerebrospinal fluid of patients with cerebrovascular accidents; demonstration of a blood-cerebrospinal-fluid barrier.

M. Kaplan, J. Lieberman, O. Daiber, 1957, The New England journal of medicine.

Profile of bronchospastic disease in Puerto Rican patients in New York City. A possible relationship to alpha 1-antitrypsin variants.

J. Lieberman, C. Colp, A. Multz, 1990 .

Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease.

A. Sastre, J. Lieberman, S. Borowsky, 1982, Archives of internal medicine.

A role for intermediate, heterozygous alpha 1-antitrypsin deficiency in obstructive lung disease.

J. Lieberman, C. Colp, 1990, Chest.

Bronchiectasis and homozygous alpha1-antitrypsin deficiency.

S. Weitzman, G. Longstreth, J. Lieberman, 1975, Chest.

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

J. Lieberman, 2000, Chest.

Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease.

J. Lieberman, C. Mittman, T. Barbela, 1973, Journal of Occupational Medicine.

Clinical syndromes associated with deficient lung fibrinolytic activity: I. A new concept of hyaline-membrane disease.

J. Lieberman, 1959, The New England journal of medicine.

The nature of the fibrinolytic-enzyme defect in hyaline-membrane disease.

J. Lieberman, 1961, The New England journal of medicine.

Serum angiotensin-converting enzyme: elevations in diabetes mellitus.

A. Sastre, J. Lieberman, 1980, Annals of internal medicine.

A new deficient variant of alpha1-antitrypsin (MDUARTE). Inability to detect the heterozygous state by antitrypsin phenotyping.

J. Lieberman, S. Klotz, L. Gaidulis, 1976, The American review of respiratory disease.

Alpha 1-antitrypsin Pi-types in 965 COPD patients.

A. Sastre, B. Winter, J. Lieberman, 1986, Chest.

Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease.

J. Lieberman, C. Mittman, J. Rumsfeld, 2015, American Review of Respiratory Disease.

Antitrypsin deficiency and abnormal protease inhibitor phenotypes.

J. Lieberman, C. Mittman, T. Barbela, 1973, Archives of environmental health.

Screening for homozygous and heterozygous alpha 1-antitrypsin deficiency. Protein electrophoresis on cellulose acetate membranes.

A. S. Schneider, J. Lieberman, C. Mittman, 1969, JAMA.

Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

J. Lieberman, 1969, The New England journal of medicine.

Variants of alpha 1-antitrypsin in Puerto Rican children with asthma.

J. Pappas, J. Lieberman, C. Colp, 1993, Chest.

Racial Distribution of α1-Antitrypsin Variants among Junior High School Students1

J. Lieberman, L. Gaidulis, L. Roberts, 2015 .

Racial distribution of alpha1-antitrypsin variants among junior high school students.

J. Lieberman, L. Gaidulis, L. Roberts, 1976, The American review of respiratory disease.

Identification and characteristics of the common alpha 1 -antitrypsin phenotypes.

B. Garoutte, J. Lieberman, C. Mittman, 1972, Chest.

Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency.

A. Yoshida, J. Lieberman, C. Ewing, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Childhood cirrhosis associated with alpha-1-antitrypsin deficiency. A genetic, biochemical, and morphologic study.

R. W. Archibald, J. Lieberman, J. Asarian, 1975, The Journal of pediatrics.

CLINICAL SPECTRUM OF ALPHA1-ANTITRYPSIN DEFICIENCY

J. Lieberman, 1975 .

Measurement of AIpha1-Antitrypsin inSerum, by Immunodiffusion andby Enzymatic Assay

O. Rennert, E. Freier, A. Dietz, 1974 .

Alpha1 Antitrypsin in the Livers of Patients with Emphysema

H. Gordon, J. Lieberman, C. Mittman, 1972, Science.

Screening for heterozygous 1 -antitrypsin deficiency. 3. A provocative test with diethylstilbestrol and effect of oral contraceptives.

J. Lieberman, C. Mittman, J. Kent, 1971, JAMA.

Serum trypsin inhibitors in coal miners.

J. Lieberman, 1971, JAMA.

Material Isolated from Normal and Variant Human Liver that Immunologically Crossreacts with Alpha 1-Antitrypsin ( pulmonary emphysema / liver cirrhosis / trypsin inhibition / antitrypsin deficiency )

A. Yoshida, J. Lieberman, S. Matsubara, 2022 .

Heat lability of alpha1-antitrypsin variants.

J. Lieberman, 1973, Chest.

Elastase, collagenase, emphysema, and alpha1-antitrypsin deficiency.

J. Lieberman, 1976, Chest.

Hyaline-membrane formation and pulmonary plasminogen-activator activity in various strains of mice.

J. Lieberman, F. Kellogg, 1967, Pediatrics.

Intermediate alpha1-antitrypsin deficiency resulting from a null gene (M-phenotype).

J. Lieberman, L. Gaidults, L. Schleissner, 1976, Chest.

α1‐Antitrypsin deficiency in severe psoriasis

R. Moy, J. Lieberman, M. Heng, 1985 .

Increased Kallikrein Content of Saliva from Patients with Cystic Fibrosis of the Pancreas: A Theory for the Pathogenesis of Abnormal Secretions

G. Littenberg, J. Lieberman, 1969, Pediatric Research.

α1‐Antitrypsin deficiency in twins and parents‐of‐twins

N. Borhani, M. Feinleib, J. Lieberman, 1979, Clinical genetics.

Alpha-1 antitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children.

R. Katz, S. Siegel, J. Lieberman, 1976, The Journal of allergy and clinical immunology.

Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis.

T. Rea, J. Lieberman, 1977, Annals of internal medicine.

Colonoscopic features of simvastatin-induced colitis suggest ischemia as an etiologic mechanism.

D. Kasimian, F. Leung, J. Lieberman, 2005, Gastrointestinal endoscopy.

Molecular abnormality of PI S variant of human alpha1-antitrypsin.

A. Yoshida, J. Lieberman, C. Ewing, 1977, American journal of human genetics.

Dynamic response of alpha1-antitrypsin variants to diethylstilbestrol.

J. Lieberman, C. Mittman, 1973, American journal of human genetics.

Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function.

A. Sastre, J. Lieberman, F. Mishkin, 1983, Chest.

Effect of converting enzyme inhibitors on serum ACE test.

J. Lieberman, 1990, Chest.

α1-Antitrypsin Deficiency

F. Kueppers, J. Lieberman, 1970 .

More on antitrypsin activity in lung disease.

J. Lieberman, C. Mittman, 1970, Annals of internal medicine.

Influence of Deoxyribonucleic Acid Content on the Proteolysis of Sputum and Pus

J. Lieberman, N. Kurnick, 1962, Nature.

Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure.

I. Lasky, J. Lieberman, S. Dulkin, 1957, Annals of internal medicine.

Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis.

J. Lieberman, 1968, JAMA.

Enzymatic dissolution of pulmonary secretions. An in vitro study of sputum from patients with cystic fibrosis of pancreas.

J. Lieberman, 1962, American journal of diseases of children.

Frequency of Heterozygous and Homozygous Alphax1-Antitrypsin Deficiencies in Patients with Pulmonary Emphysema.

J. Lieberman, 1969 .

Inhibition of trypsin by deoxyribonucleic acid.

J. Lieberman, N. Kurnick, C. McGaughey, 1965, Archives of biochemistry and biophysics.

The mechanisms of antitrypsin deficiency an their role in the pathogenesis of pulmonary emphysema

J. Lieberman, 1975, Pneumonologie.

α1-Antitrypsin Deficiency and Emphysema

J. Lieberman, C. Mittman, 1970 .

Interference with alpha-antitrypsin studues in stored serum by presumed bacterial proteases.

J. Lieberman, L. Gaidulis, W. Kaneshiro, 1975, The Journal of laboratory and clinical medicine.

Smoking and chronic obstructive lung disease in alpha-1-antitrypsin deficiency.

J. Lieberman, C. Mittman, A. Miranda, 1971, Chest.

Involvement of leukocytic proteases in emphysema and antitrypsin deficiency.

J. Lieberman, 1973, Archives of environmental health.

Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. I. Bodily trauma.

I. Lasky, J. Lieberman, S. Dulkin, 1957, Annals of internal medicine.

Enzymes in sarcoidosis. Angiotensin-converting-enzyme (ACE).

J. Lieberman, 1989, Clinics in laboratory medicine.

Relative orientation of the ciliary central pair in the immotile cilia syndrome.

J. Lieberman, 1987, Chest.

The fibrinolytic enzyme defect of hyaline membrane disease.

J. Lieberman, F. Kellogg, 1961, California medicine.

Pulmonary Plasminogen-Activator Activity in Hyaline Membrane Disease: A Reevaluation on Human, Bovine, and Rabbit Fibrin Substrates

J. Lieberman, 1969, Pediatric Research.

Fibrinolytic Activity of Arterial Tissues

J. Lieberman, F. Kellogg, 1961, Circulation research.

A deficiency of pulmonary fibrinolysis in hyaline-membrane disease.

J. Lieberman, F. Kellogg, 1960, The New England journal of medicine.

Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis.

D. Bell, J. Lieberman, 1993, The American journal of medicine.

Proteolytic Enzyme Activity in Fetal Pancreas and Meconium:Demonstration of plasminogen and trypsinogen activators in pancreatic tissue

J. Lieberman, 1966 .

Clinical syndromes associated with deficient fibrinolytic activity of the lung. II. Cystic fibrosis of the pancreas.

J. Lieberman, 1960, Pediatrics.

Lymphadenopathy in an inner-city population consisting principally of intravenous drug abusers with suspected acquired immunodeficiency syndrome.

G. Wormser, D. Hewlett, J. Lieberman, 1988, The American review of respiratory disease.

Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis.

J. Lieberman, F. Mishkin, L. Schleissner, 1979, Annals of internal medicine.

ALPHA‐1 ANTITRYPSIN DEFICIENCY IN A PATIENT WITH WIDESPREAD PRURIGO NODULARIS

A. Kim, S. Allen, J. Lieberman, 1991, The Australasian journal of dermatology.

THE SPECIFICITY AND NATURE OF SERUM‐ANGIOTENSIN‐CONVERTING ENZYME (SERUM ACE) ELEVATIONS IN SARCOIDOSIS *

J. Lieberman, 1976, Annals of the New York Academy of Sciences.

Material isolated from normal and variant human liver that immunologically crossreacts with alpha1-antitrypsin.

A. Yoshida, J. Lieberman, S. Matsubara, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Alpha 1 -antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency.

J. Dixon, H. Gordon, J. Lieberman, 1972, Human pathology.

Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.

J. Lieberman, 1974, Annals of internal medicine.

Inhibitors and activators of leukocytic proteases in purulent sputum. Digestion of human lung and inhibition by alpha 1-antitrypsin.

J. Lieberman, M. A. Gawad, 1971, The Journal of laboratory and clinical medicine.

Carboxypeptidase B-like activity and C3 in cystic fibrosis.

J. Lieberman, 1975, The American review of respiratory disease.

Serum angiotensin-converting enzyme in severe nonthyroidal illnesses associated with low serum thyroxine concentration.

A. Sastre, G. Brent, J. Hershman, 1984, Annals of internal medicine.

Low blood pressure in young adults with cystic fibrosis: an effect of chronic salt loss in sweat?

S. Rodbard, J. Lieberman, 1975, Annals of internal medicine.

Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Ionic enhancement of plasminogen activator activity.

J. Lieberman, 1968, Laboratory investigation; a journal of technical methods and pathology.

Abnormal response of cultured lymphocytes to phytohemagglutinin and autologous serum in cystic fibrosis.

J. Lieberman, W. Kaneshiro, 1977, The American review of respiratory disease.

Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia

A. Kling, K. Tachiki, J. Lieberman, 1995, Neurobiology of Aging.

Effect of menses, estrogens and hemolysis on a serum-lectin-like factor in cystic fibrosis.

K. Tachiki, J. Lieberman, 1989, Chest.

Pseudoclubbing in a patient with sarcoidosis of the phalangeal bones.

M. Krauthammer, J. Lieberman, 1983, Archives of internal medicine.

Intermediate alpha 1-antitrypsin deficiency with apical lung bullae and spontaneous pneumothorax. Presence of a Z variant in an American black.

J. Lieberman, S. Mostafavi, Jack Lieberman, 1991, Chest.

Serum angiotensin converting enzyme levels in patients with alpha1-antitrypsin variants☆

A. Sastre, J. Lieberman, 1986 .

Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis.

J. Lieberman, A. Nosal, A. Schlessner, 1979, The American review of respiratory disease.

Inhibition of leukocytic elastase from purulent sputum by alpha 1 -antitrypsin.

J. Lieberman, W. Kaneshiro, 1972, The Journal of laboratory and clinical medicine.

Lectin-like factor and co-factor in serum from cystic fibrosis heterozygotes.

J. Lieberman, W. Kaneshiro, 1984, American Journal of Medicine.

A CF-lectin factor in amniotic fluid from pregnancies at risk for cystic fibrosis.

J. Lieberman, 1991, The American journal of the medical sciences.

Assay of a urinary CF-lectin factor as a second diagnostic test for cystic fibrosis.

M. Schwartzman, J. Lieberman, 1990, The American journal of the medical sciences.

Presence of a serum hemagglutinin (lectinlike factor) in cystic fibrosis homozygotes and heterozygotes.

J. Lieberman, N. Costea, W. Kaneshiro, 1981, The Journal of laboratory and clinical medicine.

Lymphocytic acid-hydrolases and response to mitogens in cystic fibrosis.

J. Lieberman, W. Kaneshiro, 1979, Chest.

Detection of a lectin in the blood of cystic fibrosis homozygotes and heterozygotes.

J. Lieberman, N. Costea, W. Kaneshiro, 1979, Transactions of the Association of American Physicians.

Plasma arginine esterase activity in cystic fibrosis.

J. Lieberman, 1974, The American review of respiratory disease.

Proteolytic enzyme activity and the role of desoxyribose nucleic acid (DNA) in cystic fibrosis sputum.

J. Lieberman, N. Kurnick, 1963, Pediatrics.

Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis.

J. Lieberman, F. Zakria, 1989, Sarcoidosis.

Aryl hydrocarbon hydroxylase in bronchogenic carcinoma.

J. Lieberman, 1978, The New England journal of medicine.

Measurement of Sputum Viscosity in a Cone-Plate Viscometer1

J. Lieberman, 2015 .

Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.

A. Kling, K. Tachiki, J. Lieberman, 1995, Neurobiology of aging.

An angiotensin-converting enzyme (ACE) inhibitor in human serum. Increased sensitivity of the serum ACE assay for detecting active sarcoidosis.

A. Sastre, J. Lieberman, 1986, Chest.

Inhibition of protease activity in purulent sputum by DNA.

J. Lieberman, 1967, The Journal of laboratory and clinical medicine.

The multiple causes of alpha1-antitrypsin deficiency.

J. Lieberman, 1975, Pathologie et biologie.

Measurement of sputum viscosity in a cone-plate viscometer. I. Characteristics of sputum viscosity.

J. Lieberman, 1968, The American review of respiratory disease.

Simplified alpha1-antitrypsin phenotyping by immunofixation of acid-starch gels.

J. Lieberman, L. Gaidulis, 1976, The Journal of laboratory and clinical medicine.

In vitro evaluation of the mucolytic action of urea.

J. Lieberman, 1967, JAMA.

SUBSTRATE SPECIFICITY OF PROTEASE ACTIVITIES IN PURULENT SPUTUM.

J LIEBERMAN, B M TRIMMER, N B KURNICK, 1965, Laboratory investigation; a journal of technical methods and pathology.